Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the site. This change does not appear to modify the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-05-15T05:46:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:59:03.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:40:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma as a related MeSH term and added a Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:41.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:59:31.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:32.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.